Ozette Technologies is a life science data company that accelerates the development of therapies and diagnostics by digitizing immune data.
Ozette Technologies has raised $26.0M in total funding. The most recent round was Series A. The last funding was announced in July 2022.
Ozette Technologies's investors include Madrona, Allen Institute for Artificial Intelligence, Alexandria Venture Investments, M12 - Microsoft's Venture Fund, Duke University.
Ozette Technologies is headquartered in Seattle, United States.
Ozette Technologies is a life science data company that accelerates the development of therapies and diagnostics by digitizing immune data.
Ozette Technologies is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Ozette Technologies — Funding & Investors." VCBacked, July 28, 2022, https://www.vcbacked.co/company/ozette-technologies. Accessed August 11, 2026.
VCBacked. (2022). Ozette Technologies — Funding & Investors. Retrieved August 11, 2026, from https://www.vcbacked.co/company/ozette-technologies
{{cite web |title=Ozette Technologies — Funding & Investors |url=https://www.vcbacked.co/company/ozette-technologies |website=VCBacked |access-date=August 11, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated